drugset / Trial / NCT07015918

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

NCT07015918

Phase 1 Completed 8 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to learn about how much the study medicine PF-07976016 will be taken up and processed by healthy male participants. The total number of weeks of the study is up to approximately 12 weeks.

Timeline

Start
2025-06-04
Primary completion
2025-07-16
Completion
2025-08-14

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-07976016 Unknown Oral

Indications

No indication recorded.